-
Using Antibodies to Confirm Sticky Alpha-synuclein as the Cause of Parkinson's Disease
… disease (PD), but it is unclear what prompts it to clump. Researchers believe that in PD the structure and amount of … samples from individuals with and without PD to identify early causes of disease. Hypothesis: We hypothesize that … of them can serve as reliable disease signs. Impact on Diagnosis/Treatment of Parkinson's disease: Knowing how the …
-
The Michael J. Fox Foundation for Parkinson's Research and The Bachmann-Strauss Dystonia and Parkinson Foundation Announce New Collaborative Research Alliance
September 17, 2014
… Outing Today, The Michael J. Fox Foundation for Parkinson’s Research (MJFF) and The Bachmann-Strauss Dystonia and … Parkinson Foundation (BSDPF) announced a new collaborative research alliance to raise awareness and deepen investment … and MJFF have shared a productive working relationship for nearly a decade, collaborating on major studies, sharing …
-
Research Roundup: Recruiting Studies Aiming to Treat or Stop Parkinson’s
September 20, 2022
… you have Parkinson’s disease (PD) or not, participating in research is a way to contribute toward a cure. Some studies … types of studies are critical for speeding a cure. In this research roundup blog, we share a handful of studies … eligible must be 40-80 years of age, have a confirmed PD diagnosis, and have never received deep brain …
-
Developing an Open-access Repository of High-quality Digital Measurement Tools for Use in Parkinson’s Disease Research and Care
… measures, measurement tools and datasets for use in PD research and clinical care. This effort will build upon … library of high-value digital solutions to support the PD research and care communities. Hypothesis: We hypothesize … seeking to develop products to meet their needs. Impact on Diagnosis/Treatment of Parkinson’s disease: Broad adoption …
-
Three Questions for a Researcher with Erwan Bezard, PhD, INSERM Research Director at the Institute of Neurodegenerative Diseases (IND) in Bordeaux, France
April 8, 2013
… Erwan Bezard heads a novel research center, the Institute of Neurodegenerative Diseases … together pre-clinical laboratory scientists with clinical researchers, who share in the development of potential … in the latest of our monthly feature, Three Questions for a Researcher . Read on to get to know him and his work a …
-
NIC-PD Trial to Assess the Disease-modifying Potential of Transdermal Nicotine in Early Parkinson's Disease
… transdermal nicotine (nicotine patches) in patients at very early stages of Parkinson’s disease who do not yet require … the patient, symptomatic therapy is allowed. Relevance to Diagnosis/Treatment of Parkinson’s Disease : The … the United States. Progress Report Results are expected in early 2017. October 2016 Learn More NIC-PD Launches …